Merck Insomnia Drug Safe Only in Low Doses

May 23 (Bloomberg) -- Merck & Co.’s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi’s Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
China Will Do What Is Needed to Boost Growth: Street
06:44 - Bill Street of State Street Global Advisors talks with Anna Edwards about the boost to Chinese manufacturing from stimulus measures and the seven-year high hit by the Shanghai Composite. He speaks on “On The Move.” (Source: Bloomberg)
  • Challenger Muhammadu Buhari Wins Nigeria's Presidency
  • Parity for Euro by End of the Year: BNP Paribas
  • ECB to Review Lifeline to Greek Banks